VESCOVI ANGELO LUIGI

Leone, M., Gelati, M., Profico, D., Gobbi, C., Pravata, E., Copetti, M., et al. (2023). Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis. CELL STEM CELL, 30(12), 1597-1609 [10.1016/j.stem.2023.11.001]. Detail

Rotundo, G., Turco, E., Ruotolo, G., Torrente, I., Candido, O., Lopez, G., et al. (2023). Generation of an induced pluripotent stem cell line CSSi015-A (9553), carrying a point mutation c.2915C > T in the human calcium sensing receptor (CasR) gene. STEM CELL RESEARCH, 67(March 2023), 1-5 [10.1016/j.scr.2023.103023]. Detail

Grespi, V., Caprera, C., Ricciolini, C., Bicchi, I., Muzi, G., Corsi, M., et al. (2022). Human neural stem cells drug product: Microsatellite instability analysis. PLOS ONE, 17(8) [10.1371/journal.pone.0273679]. Detail

Ferrari, D., D'Anzi, A., Casamassa, A., Bernardini, L., Tata, A., Vescovi, A., et al. (2022). Functional outcomes of copy number variations of Chrna7 gene: Current knowledge and new insight from induced pluripotent stem cells studies. In A. Birbrair (a cura di), Novel Concepts in iPSC Disease Modeling (pp. 269-306). Academic Press [10.1016/B978-0-12-823882-0.00012-6]. Detail

Perciballi, E., Bovio, F., Rosati, J., Arrigoni, F., D'Anzi, A., Lattante, S., et al. (2022). Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients. ANTIOXIDANTS, 11(5) [10.3390/antiox11050815]. Detail